Delivery Order SPE2DB22D1106-SPE2DB24FDUV0
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The delivery order has a potential value of $1,994.08 and a completion date of January 17, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. As...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $2,227.77 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award and has received numerous prior contracts from DLA Troop Support Medical to provide...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,349.02 contract is for the supply of ENDOCET 10-325 MG TABLET 100S, a prescription medication. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $2,850.78, is for the delivery of 4,564,005,666 tablets of ENDOCET 10-325 MG, a prescription pain medication, to support military treatment programs and facilities. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.24 firm fixed-price delivery order is for ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,586.03 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a medication used for pain management. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.36 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,012.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB24FDKF6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.68 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. It is not designated as a set-aside contract....
This federal contract award SPE2DB22D1106|SPE2DB24FEVH1, valued at $1,469.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENDOCET 10-325 MG TABLET 100S. The contract has an ultimate completion date of June 5, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...